Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer.

Anders BojessonEva BrunJakob EberhardMikael Segerlantz

Published in: Acta oncologica (Stockholm, Sweden) (2021)

Poor performance status and hypoalbuminemia are negative prognostic factors for survival on SL palliative treatment in patients with advanced pancreatic cancer. Possible gain in survival should be carefully considered before initiating SL chemotherapy.

Keyphrases

prognostic factors
free survival
palliative care
locally advanced
advanced cancer
combination therapy